Credit Suisse reiterated coverage on SOC Telemed with a new price target
$TLMD
Managed Health Care
Health Care
Credit Suisse reiterated coverage of SOC Telemed with a rating of Outperform and set a new price target of $8.50 from $11.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/1/2022 | $3.00 | Neutral | Credit Suisse |
| 2/7/2022 | $2.00 → $3.00 | Neutral | Credit Suisse |
| 2/4/2022 | Buy → Hold | Benchmark | |
| 2/3/2022 | $6.00 → $3.00 | Outperform → Sector Perform | RBC Capital |
| 2/3/2022 | $4.00 → $3.00 | Outperform → Neutral | Baird |
| 1/7/2022 | $6.00 → $2.00 | Outperform → Neutral | Credit Suisse |
| 8/13/2021 | $10.00 → $6.00 | Outperform | RBC Capital |
| 8/13/2021 | $11.00 → $8.50 | Outperform | Credit Suisse |
Credit Suisse resumed coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00
Credit Suisse reiterated coverage of SOC Telemed with a rating of Neutral and set a new price target of $3.00 from $2.00 previously
Benchmark downgraded SOC Telemed from Buy to Hold